Recombinant CD4‐IgG2 in Human Immunodeficiency Virus Type 1–Infected Children: Phase 1/2 Study

Abstract

The use of recombinant CD4-IgG2 in pediatrie human immunodeficiency virus type 1 (HIV-1) infection was evaluated by single and multidose intravenous